Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 6 peer-reviewed journal articles Updated
Gastroenterology

Medications for Gastroparesis

At a Glance

Medications for gastroparesis fall into two main categories: prokinetics, which help the stomach empty, and antiemetics, which control nausea. Treatment often involves balancing the benefits of drugs like metoclopramide or domperidone against risks such as tardive dyskinesia or heart rhythm changes.

Medications for gastroparesis generally fall into two categories: prokinetics, which help the stomach move food along, and antiemetics, which help control nausea and vomiting [1][2]. Because every patient responds differently, finding the right combination often requires careful discussion with your doctor and pharmacist [3].

Prokinetics: Moving the Stomach

These medications target the underlying “paralysis” by encouraging the stomach muscles to contract and the pylorus (the exit valve) to open.

Medication Benefit Risk / Warning
Metoclopramide (Reglan) The only FDA-approved drug for GP. Works for both motility and nausea. Black Box Warning: Tardive Dyskinesia (TD), a potentially permanent twitching disorder. Use is typically limited to <12 weeks [1].
Domperidone Effective prokinetic that does not cross the blood-brain barrier (lower risk of twitching/TD). Not FDA-approved (available via IND/Canada). Risk of heart rhythm changes (QT prolongation); requires EKG monitoring.
Erythromycin Powerful antibiotic that stimulates stomach contractions. Good for flares. Tachyphylaxis: The body gets used to it quickly, and it stops working after a few weeks.
Prucalopride (Motegrity) “Off-label” use. Stimulates movement through the whole gut. generally well-tolerated but may cause headache or diarrhea.

Antiemetics: Controlling Symptoms

If moving the stomach is not enough, anti-nausea medications are used to improve your quality of life.

  • Ondansetron (Zofran): A very common and effective anti-nausea medication. It is generally well-tolerated but, like many gastroparesis drugs, it can impact the heart’s rhythm in some patients.
  • Promethazine (Phenergan): This is a stronger anti-nausea drug that also has sedative properties. It is often used for severe nausea but can cause significant drowsiness and “brain fog.”
  • Intranasal Metoclopramide (Gimoti): A nasal spray version of metoclopramide. This is helpful for patients who vomit up pills before they can be absorbed [4].

Emerging & Off-Label Options

Medical research is ongoing for new treatments, such as G-POEM (a procedure to relax the stomach’s exit valve) and newer prokinetic drugs that target specific receptors in the gut without affecting the brain or heart as significantly [5][6]. Always consult your medical team before starting or stopping any medication, as many of these drugs can interact with each other or with underlying conditions like diabetes.

Common questions in this guide

What is the major safety warning for taking Metoclopramide (Reglan)?
Metoclopramide (Reglan) carries a "black box warning" for tardive dyskinesia, a potentially permanent disorder causing involuntary muscle movements. Because of this risk, usage is typically limited to less than 12 weeks to ensure patient safety.
How is Domperidone different from Metoclopramide?
Domperidone is often considered an alternative because it does not cross the blood-brain barrier, significantly lowering the risk of twitching or tardive dyskinesia. However, it is not FDA-approved in the US and requires monitoring for heart rhythm changes.
Why does Erythromycin often stop working for gastroparesis?
Erythromycin is a powerful antibiotic that stimulates stomach contractions, but the body often gets used to it quickly, a process called tachyphylaxis. This means it may stop working effectively after a few weeks of use.
When is the nasal spray version of metoclopramide used?
Intranasal metoclopramide (Gimoti) is a nasal spray version of the drug. It is particularly helpful for patients who vomit frequently and cannot keep oral pills down long enough for them to be absorbed.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.If I am prescribed Metoclopramide, what is the safest dose and duration for me to minimize my risk of tardive dyskinesia?
  2. 2.Should I have an EKG before starting medications like Domperidone or Erythromycin to check my heart's rhythm (QT interval)?
  3. 3.How will we know if Erythromycin has stopped working due to tachyphylaxis, and what is our backup plan if that happens?
  4. 4.Is Prucalopride an appropriate off-label option for me if the standard prokinetics aren't working?
  5. 5.Which antiemetic, such as Ondansetron or Promethazine, is safest for me to use for breakthrough nausea given my other medications?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Why Did Erythromycin Stop Working for Gastroparesis?

References

References (6)
  1. 1

    Diabetic Gastroparesis: Perspectives From a Patient and Health Care Providers.

    Farmer AD, Bruckner-Holt C, Schwartz S, et al.

    Journal of patient-centered research and reviews 2019; (6(2)):148-157 doi:10.17294/2330-0698.1689.

    PMID: 31414026
  2. 2

    [Gastroparesis - causes, diagnosis and treatment].

    Sangnes DA, Søfteland E, Biermann M, et al.

    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 2016; (136(9)):822-6 doi:10.4045/tidsskr.15.0503.

    PMID: 27221182
  3. 3

    Gastroparesis.

    Camilleri M, Chedid V, Ford AC, et al.

    Nature reviews. Disease primers 2018; (4(1)):41 doi:10.1038/s41572-018-0038-z.

    PMID: 30385743
  4. 4

    Metoclopramide nasal spray for management of symptoms of acute and recurrent diabetic gastroparesis in adults.

    Gajendran M, Sarosiek I, McCallum R

    Expert review of endocrinology & metabolism 2021; (16(2)):25-35 doi:10.1080/17446651.2021.1886922.

    PMID: 33739209
  5. 5

    Redefining the Treatment Landscape in Gastroparesis: A Clinical Review of Gastric Peroral Endoscopic Myotomy Outcomes and Therapeutic Integration.

    Essilfie-Quaye K, Creamer C, Abuassi M, et al.

    DEN open 2026; (6(1)):e70260 doi:10.1002/deo2.70260.

    PMID: 41378163
  6. 6

    Velusetrag accelerates gastric emptying in subjects with gastroparesis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 study.

    Kuo B, Barnes CN, Nguyen DD, et al.

    Alimentary pharmacology & therapeutics 2021; (53(10)):1090-1097 doi:10.1111/apt.16344.

    PMID: 33811761

This medication guide is for educational purposes only and does not replace professional pharmaceutical or medical advice. Always discuss side effects and drug interactions with your prescribing doctor.

Get notified when new evidence is published on Gastroparesis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.